Valley Biomedical Products & Services, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Valley Biomedical Products & Services, Inc. - overview

Established

1986

Location

-, VA, US

Primary Industry

Biotechnology

About

Based in Virginia, US, and founded in 1986, Valley Biomedical Products & Services, Inc. operates as a provider of contract manufacturing services and operator of biologicals and diagnostic reagent products for clinical diagnostics markets, biotechnology, and research and development. The company was acquired by BioIVT in 2021. The company is comprised of three business segments which include research products and cell culture sera, human and animal source blood products manufactured to customer specifications, and non-biological liquid reagents.


It is also an FDA-registered medical device manufacturer which primarily focuses in vitro diagnostics (IVDs).


Current Investors

BioIVT, LLC

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Medical Supplies, Pharmaceutical Research & Development

Website

www.valleybiomedical.com

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Valley Biomedical Products & Services, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedValley Biomedical Products & Services, Inc.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.